Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
BMJ Open|July 24, 2023
Simulation modelling to study the impact of adding comprehensive stroke centres. Can we deliver endovascular thrombectomy sooner?Willemijn J Maas, Durk-Jouke van der Zee, Erik Buskens, et al.BMJ Open|April 7, 2022
Expediting workflow in the acute stroke pathway for endovascular thrombectomy in the northern Netherlands: a simulation modelWillemijn J Maas, Maarten M H Lahr, Maarten Uyttenboogaart, et al.Stroke|October 19, 2020
Pathway Design for Acute Stroke Care in the Era of Endovascular Thrombectomy: A Critical Overview of Optimization EffortsWillemijn J Maas, Maarten M H Lahr, Erik Buskens, et al.BMJ Open|January 10, 2020
Rationale and design for studying organisation of care for intra-arterial thrombectomy in the Netherlands: simulation modelling studyMaarten M H Lahr, Willemijn J Maas, Durk-Jouke van der Zee, et al.BMC Health Services Research|July 20, 2023
'Drive the doctor' for endovascular thrombectomy in a rural area: a simulation studyWillemijn J Maas, Durk-Jouke van der Zee, Maarten M H Lahr, et al.BMC Health Services Research|March 30, 2023
Cost-effectiveness of improvement strategies for reperfusion treatments in acute ischemic stroke: a systematic reviewChi Phuong Nguyen, Willemijn J Maas, Durk-Jouke van der Zee, et al.BMJ Open|March 29, 2025
Drive-the-doctor paradigm in acute ischaemic stroke for improving regional stroke care networks: a cost-effectiveness analysisChi Phuong Nguyen, Maarten Uyttenboogaart, Willemijn J Maas, et al.Lung Cancer (Amsterdam, Netherlands)|December 21, 2024
CT-assessed sarcopenia and immune-related adverse events in patients with lung cancer: A competing risk time-to-event analysisErick Suazo-Zepeda, Alain R Viddeleer, Willemijn J Maas, et al.Translational Lung Cancer Research|October 21, 2024
Trends in the prescription of immune checkpoint inhibitors for non-small cell lung cancer in the Netherlands from 2016 to 2020, a national cancer registry analysisErick Suazo-Zepeda, Willemijn J Maas, Petra C Vinke, et al.BMJ Open|February 20, 2025
Changes in global quality of life after treatment with immune checkpoint inhibitors in patients receiving different treatment regimens for advanced stage lung cancer in the Netherlands: a 2015-2021 cohort studyAnanya Malhotra, Erick Suazo-Zepeda, Petra C Vinke, et al.Pageof 2